Skip to main content
Erschienen in: Clinical and Translational Oncology 10/2019

20.04.2019 | Research Article

Comparison of overall survival and quality of life between patients undergoing anal reconstruction and patients undergoing traditional lower abdominal stoma after radical resection

verfasst von: P. Du, S.-Y. Wang, P.-F. Zheng, J. Mao, H. Hu, Z.-B. Cheng

Erschienen in: Clinical and Translational Oncology | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Miles procedure is often necessary for patients with low rectal carcinoma. However, this operation often affects the quality of life of patients, to evaluate the advantages of improved operation (anal reconstruction), the quality of life and survival between patients undergoing anal reconstruction and patients undergoing traditional lower abdominal stoma after radical resection were analyzed.

Methods

The clinical data of 43 patients with low situated rectal carcinoma were retrospectively analyzed. 23 patients with left lower abdominal stoma after radical resection (Miles procedure) were divided into group A, and 20 patients with reconstruction of the anus in situ after radical resection were in group B. All patients were investigated by the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-CR38 questionnaire, the clinical data are recorded. Independent sample T test was used to analyze the difference in quality of life between group A and group B at 3, 6, and 12 months after surgery, and Kaplan–Meier was used to compare the difference in overall survival between group A and group B.

Results

The results of T test showed that there were statistical significance in global health status and physical functioning between group A and group B at 3 and 6 months, but no statistical significance at 12 months (P = 0.024, P = 0.019, P = 0.115 for global health status; P = 0.004, P = 0.006, P = 0.065 for physical functioning, respectively). Emotional functioning and social functioning were also statistically significant between group A and group B at 3, 6, and 12 months (P = 0.041, P = 0.040, P = 0.034 for Emotional functioning; P = 0.020, P = 0.009, P = 0.032 for social functioning, respectively). This study also found that there was no statistical significance in body image and sexual functioning between group A and group B at 3 months, but there was statistical significance at 6 and 12 months(P = 0.098, P = 0.035, P = 0.045 for body image; P = 0.110, P = 0.048, P = 0.047 for sexual functioning, respectively). There were statistically significant about sexual enjoyment and defecation problems at 3, 6, and 12 months (P = 0.023, P = 0.028, P = 0.050 for sexual enjoyment; P = 0.013, P = 0.011, P = 0.050 for defecation problems, respectively).The results of Kaplan–Meier showed that the overall survival (OS) between group A and group B was not statistically significant (χ2 = 0.600, P = 0.439).

Conclusions

There was no difference in survival time between group A and group B, but compared with the patients with left lower abdominal stoma(group A), the quality of life was better in patients with reconstruction of the anus in situ (group B). It is significant to improve the traditional lower abdominal stoma operation.
Literatur
1.
Zurück zum Zitat Schreckenbach T, Zeller MV, El Youzouri H, et al. Identification of factors predictive of postoperative morbidity and short-term mortality in older patients after colorectal carcinoma resection: a single-center retrospective study[J]. J Geriatr Oncol. 2018;9:649–58.CrossRefPubMed Schreckenbach T, Zeller MV, El Youzouri H, et al. Identification of factors predictive of postoperative morbidity and short-term mortality in older patients after colorectal carcinoma resection: a single-center retrospective study[J]. J Geriatr Oncol. 2018;9:649–58.CrossRefPubMed
4.
Zurück zum Zitat Mouchli MA, Ouk L, Scheitel MR, et al. Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancer[J]. World J Gastroenterol. 2018;24(8):905–16.CrossRefPubMedPubMedCentral Mouchli MA, Ouk L, Scheitel MR, et al. Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancer[J]. World J Gastroenterol. 2018;24(8):905–16.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Iwamoto M, Kawada K, Hida K, et al. Delayed anastomotic leakage following laparoscopic intersphincteric resection for lower rectal cancer: report of four cases and literature review[J]. World J Surg Oncol. 2017;15(1):143.CrossRefPubMedPubMedCentral Iwamoto M, Kawada K, Hida K, et al. Delayed anastomotic leakage following laparoscopic intersphincteric resection for lower rectal cancer: report of four cases and literature review[J]. World J Surg Oncol. 2017;15(1):143.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Zając O, Spychała A, Murawa D, et al. Quality of life assessment in patients with a stoma due to rectal cancer[J]. Rep Pract Oncol Radiother. 2008;13(3):130–4.CrossRef Zając O, Spychała A, Murawa D, et al. Quality of life assessment in patients with a stoma due to rectal cancer[J]. Rep Pract Oncol Radiother. 2008;13(3):130–4.CrossRef
7.
Zurück zum Zitat Elfeki H, Thyo A, Nepogodiev D, et al. Patient and healthcare professional perceptions of colostomy-related problems and their impact on quality of life following rectal cancer surgery[J]. BJS Open. 2018;2(5):336–44.CrossRefPubMedPubMedCentral Elfeki H, Thyo A, Nepogodiev D, et al. Patient and healthcare professional perceptions of colostomy-related problems and their impact on quality of life following rectal cancer surgery[J]. BJS Open. 2018;2(5):336–44.CrossRefPubMedPubMedCentral
8.
9.
Zurück zum Zitat Methy N, Bedenne L, Bonnetain F. Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists[J]. BMC Cancer. 2010;10:277.CrossRefPubMedPubMedCentral Methy N, Bedenne L, Bonnetain F. Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists[J]. BMC Cancer. 2010;10:277.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Du P, Xu B, Zhang D, et al. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma[J]. Oncotarget. 2017;8(1):954–66.CrossRefPubMed Du P, Xu B, Zhang D, et al. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma[J]. Oncotarget. 2017;8(1):954–66.CrossRefPubMed
11.
Zurück zum Zitat Kim JW. The quality of life after rectal cancer surgery[J]. Korean J Gastroenterol. 2006;47(4):295–9.PubMed Kim JW. The quality of life after rectal cancer surgery[J]. Korean J Gastroenterol. 2006;47(4):295–9.PubMed
12.
Zurück zum Zitat Souza J, Nahas CSR, Nahas SC, et al. Health-related quality of life assessment in patients with rectal cancer treated with curative intent[J]. Arq Gastroenterol. 2018;55(2):154–9.CrossRefPubMed Souza J, Nahas CSR, Nahas SC, et al. Health-related quality of life assessment in patients with rectal cancer treated with curative intent[J]. Arq Gastroenterol. 2018;55(2):154–9.CrossRefPubMed
13.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology[J]. J Natl Cancer Inst. 1993;85(5):365–76.CrossRef Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology[J]. J Natl Cancer Inst. 1993;85(5):365–76.CrossRef
14.
Zurück zum Zitat Sprangers MA, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR14). European Organization for Research and Treatment of Cancer Study Group on Quality of Life[J]. Eur J Cancer. 1999;35(2):238–47.CrossRefPubMed Sprangers MA, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR14). European Organization for Research and Treatment of Cancer Study Group on Quality of Life[J]. Eur J Cancer. 1999;35(2):238–47.CrossRefPubMed
15.
Zurück zum Zitat Lin JK, Tan EC, Yang MC. Comparing the effectiveness of capecitabine versus 5-fluorouracil/leucovorin therapy for elderly Taiwanese stage III colorectal cancer patients based on quality-of-life measures (QLQ-C30 and QLQ-CR1) and a new cost assessment tool[J]. Health Qual Life Outcomes. 2015;13:61.CrossRefPubMedPubMedCentral Lin JK, Tan EC, Yang MC. Comparing the effectiveness of capecitabine versus 5-fluorouracil/leucovorin therapy for elderly Taiwanese stage III colorectal cancer patients based on quality-of-life measures (QLQ-C30 and QLQ-CR1) and a new cost assessment tool[J]. Health Qual Life Outcomes. 2015;13:61.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat World Medical A. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects[J]. Bull World Health Organ. 2001;79(4):373–4. World Medical A. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects[J]. Bull World Health Organ. 2001;79(4):373–4.
17.
Zurück zum Zitat Kopp I, Bauhofer A, Koller M. Understanding quality of life in patients with colorectal cancer: comparison of data from a randomised controlled trial, a population based cohort study and the norm reference population[J]. Inflamm Res. 2004;53(Suppl 2):S130–5.PubMed Kopp I, Bauhofer A, Koller M. Understanding quality of life in patients with colorectal cancer: comparison of data from a randomised controlled trial, a population based cohort study and the norm reference population[J]. Inflamm Res. 2004;53(Suppl 2):S130–5.PubMed
18.
Zurück zum Zitat The World Cancer. Report—the major findings[J]. Cent. Eur J Public Health. 2003;11(3):177–9. The World Cancer. Report—the major findings[J]. Cent. Eur J Public Health. 2003;11(3):177–9.
19.
Zurück zum Zitat Reinwalds M, Blixter A, Carlsson E. A descriptive, qualitative study to assess patient experiences following stoma reversal after rectal cancer surgery[J]. Ostomy Wound Manag. 2017;63(12):29–37. Reinwalds M, Blixter A, Carlsson E. A descriptive, qualitative study to assess patient experiences following stoma reversal after rectal cancer surgery[J]. Ostomy Wound Manag. 2017;63(12):29–37.
20.
Zurück zum Zitat Nasvall P, Dahlstrand U, Lowenmark T, et al. Quality of life in patients with a permanent stoma after rectal cancer surgery[J]. Qual Life Res. 2017;26(1):55–64.CrossRefPubMed Nasvall P, Dahlstrand U, Lowenmark T, et al. Quality of life in patients with a permanent stoma after rectal cancer surgery[J]. Qual Life Res. 2017;26(1):55–64.CrossRefPubMed
21.
Zurück zum Zitat Herrle F, Sandra-Petrescu F, Weiss C, et al. Quality of life and timing of stoma closure in patients with rectal cancer undergoing low anterior resection with diverting stoma: a multicenter longitudinal observational study[J]. Dis Colon Rectum. 2016;59(4):281–90.CrossRefPubMed Herrle F, Sandra-Petrescu F, Weiss C, et al. Quality of life and timing of stoma closure in patients with rectal cancer undergoing low anterior resection with diverting stoma: a multicenter longitudinal observational study[J]. Dis Colon Rectum. 2016;59(4):281–90.CrossRefPubMed
22.
Zurück zum Zitat Segalla JG, Van Eyll B, Federico MH, et al. Evaluation of quality of life in patients with metastatic colorectal cancer treated with capecitabine[J]. Clin Colorectal Cancer. 2008;7(2):126–33.CrossRefPubMed Segalla JG, Van Eyll B, Federico MH, et al. Evaluation of quality of life in patients with metastatic colorectal cancer treated with capecitabine[J]. Clin Colorectal Cancer. 2008;7(2):126–33.CrossRefPubMed
23.
Zurück zum Zitat Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy[J]. Cochrane Database Syst Rev. 2012;12:CD004323.PubMed Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy[J]. Cochrane Database Syst Rev. 2012;12:CD004323.PubMed
24.
Zurück zum Zitat Neuman HB, Park J, Fuzesi S, et al. Rectal cancer patients’ quality of life with a temporary stoma: shifting perspectives[J]. Dis Colon Rectum. 2012;55(11):1117–24.CrossRefPubMed Neuman HB, Park J, Fuzesi S, et al. Rectal cancer patients’ quality of life with a temporary stoma: shifting perspectives[J]. Dis Colon Rectum. 2012;55(11):1117–24.CrossRefPubMed
25.
Zurück zum Zitat Cakmak A, Aylaz G, Kuzu MA. Permanent stoma not only affects patients’ quality of life but also that of their spouses[J]. World J Surg. 2010;34(12):2872–6.CrossRefPubMed Cakmak A, Aylaz G, Kuzu MA. Permanent stoma not only affects patients’ quality of life but also that of their spouses[J]. World J Surg. 2010;34(12):2872–6.CrossRefPubMed
26.
Zurück zum Zitat Sideris L, Zenasni F, Vernerey D, et al. Quality of life of patients operated on for low rectal cancer: impact of the type of surgery and patients’ characteristics[J]. Dis Colon Rectum. 2005;48(12):2180–91.CrossRefPubMed Sideris L, Zenasni F, Vernerey D, et al. Quality of life of patients operated on for low rectal cancer: impact of the type of surgery and patients’ characteristics[J]. Dis Colon Rectum. 2005;48(12):2180–91.CrossRefPubMed
Metadaten
Titel
Comparison of overall survival and quality of life between patients undergoing anal reconstruction and patients undergoing traditional lower abdominal stoma after radical resection
verfasst von
P. Du
S.-Y. Wang
P.-F. Zheng
J. Mao
H. Hu
Z.-B. Cheng
Publikationsdatum
20.04.2019
Verlag
Springer International Publishing
Erschienen in
Clinical and Translational Oncology / Ausgabe 10/2019
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-019-02106-x

Weitere Artikel der Ausgabe 10/2019

Clinical and Translational Oncology 10/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.